DiamondTemp Global Registry

Status Recruiting

Clinical Trial Summary

The DiamondTemp™ Global Registry is a prospective, global, multi-center, observational post-market registry.

Clinical Trial Description

The DiamondTemp™ Global Registry is a prospective, global, multi-center, observational post-market registry. The purpose of this clinical study is to describe clinical performance and safety data in a broad patient population treated with the commercially available DiamondTemp™ Family of Cardiac Ablation Catheters (hereafter referred to as the DiamondTemp™ Ablation System) and followed according to the standard of care at each respective institution. The follow up period is intended to align with standard practice and subjects will be followed for a minimum of 12 months post-procedure. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04735016
Study type	Observational [Patient Registry]
Source	Medtronic Cardiac Rhythm and Heart Failure
Contact	Ryan Radtke
Phone	712.941.9372
Email	ryan.s.radtke@medtronic.com
Status	Recruiting
Phase
Start date	April 22, 2021
Completion date	March 2031

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05048602` - Drug-induced Brugada Syndrome Research Database
Completed	`NCT05053243` - Clinical Validation of the AliveCor Kardia 12L and 6L Devices	N/A
Completed	`NCT01913561` - The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection	N/A
Completed	`NCT01688648` - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft	N/A
Completed	`NCT01396226` - A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients	Phase 2
Terminated	`NCT00624520` - Mental Stress Reduction in Defibrillator Patients	Phase 3
Terminated	`NCT00721149` - NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study	Phase 3
Completed	`NCT00756886` - Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study	N/A
Completed	`NCT00510029` - Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously	Phase 1
Completed	`NCT00578617` - Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial	N/A
Active, not recruiting	`NCT00135174` - Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study	N/A
Completed	`NCT00119847` - Electrophysiological Effects of Late PCI After MI	N/A
Completed	`NCT00035490` - Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators	Phase 3
Completed	`NCT00023556` - Genetic Architecture of Heart Disease in Rural Brazil	N/A
Completed	`NCT00004560` - Public Access Defibrillation (PAD) Community Trial	Phase 3
Completed	`NCT01076361` - Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study	N/A
Recruiting	`NCT00138931` - Genetics of Cardiovascular and Neuromuscular Disease
Completed	`NCT01076348` - Model 4965 Post-Approval Study
Completed	`NCT00622453` - Arrhythmias in Myotonic Muscular Dystrophy	N/A
Completed	`NCT00000531` - Antiarrhythmics Versus Implantable Defibrillators (AVID)	Phase 3